MCDONNELL MICHAEL R 1121897 Data last updated 2024-05-15 07:34:05 -0500 US CDT
Latest Holdings
Notice: Data summarized from Form 3,4,5 filings, which do not include holdings/transactions of investment institution(s), if any, managed by the reporter.
Non-derivative Transactions CSV download
Tips: type "code_s" to show transactions with code "S".
| Filing Date | Transaction Date | Operation Date | Original Filing | Reporter | Relation | Opr | Amounta | %(Owned)b | ‱(SO)c | Avg Prcd | Account | Type | Full Name | Code | Remain | Shares Outstanding (Million)e |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2023-05-22 | 2023-05-18 | 2023-05-18 | 4 | Mcdonnell Michael R | DIRECTOR | acq | 2262.0 | 42.58 | 0.39 | 0.0 | Direct | Common Stock, No | MERIT MEDICAL SYSTEMS INC | code A | 5312.0 | 57.49 (MMSI) |
| 2023-09-06 | 2023-09-01 | 2023-09-01 | 4 | Mcdonnell Michael R | EVP, CHIEF FINANCIAL OFFICER | dsp | 2704.0 | 17.52 | 0.19 | 267.17 | Direct | Common Stock | BIOGEN INC. | code F | 12728.0
|
144.82 (BIIB) |
| 2023-09-06 | 2023-09-01 | 2023-09-01 | 4 | Mcdonnell Michael R | EVP, CHIEF FINANCIAL OFFICER | acq | 5285.0 | 37.59 | 0.36 | 0.0 | Direct | Common Stock | BIOGEN INC. | code M | 14060.0
|
144.82 (BIIB) |
| 2024-02-09 | 2024-02-07 | 2024-02-08 | 4 | Mcdonnell Michael R | EVP, CHIEF FINANCIAL OFFICER | acq | 2335.0 | 15.5 | 0.16 | 0.0 | Direct | Common Stock | BIOGEN INC. | code M | 15063.0 | 144.9 (BIIB) |
| 2024-02-09 | 2024-02-07 | 2024-02-08 | 4 | Mcdonnell Michael R | EVP, CHIEF FINANCIAL OFFICER | dsp | 765.0 | 5.08 | 0.05 | 240.3 | Direct | Common Stock | BIOGEN INC. | code F | 14298.0 | 144.9 (BIIB) |
| 2024-02-13 | 2024-02-09 | 2024-02-09 | 4 | Mcdonnell Michael R | EVP, CHIEF FINANCIAL OFFICER | acq | 3257.0 | 18.55 | 0.22 | 0.0 | Direct | Common Stock | BIOGEN INC. | code M | 17555.0 | 144.9 (BIIB) |
| 2024-02-13 | 2024-02-09 | 2024-02-09 | 4 | Mcdonnell Michael R | EVP, CHIEF FINANCIAL OFFICER | dsp | 1431.0 | 8.15 | 0.1 | 240.98 | Direct | Common Stock | BIOGEN INC. | code F | 16124.0 | 144.9 (BIIB) |
| 2024-02-21 | 2024-02-16 | 2024-02-16 | 4 | Mcdonnell Michael R | EVP, CHIEF FINANCIAL OFFICER | acq | 6720.0 | 32.77 | 0.46 | 0.0 | Direct | Common Stock | BIOGEN INC. | code M | 20507.0
|
145.36 (BIIB) |
| 2024-02-21 | 2024-02-16 | 2024-02-16 | 4 | Mcdonnell Michael R | EVP, CHIEF FINANCIAL OFFICER | dsp | 3438.0 | 15.05 | 0.24 | 219.08 | Direct | Common Stock | BIOGEN INC. | code F | 19406.0
|
145.36 (BIIB) |
Derivative Transactions
Tips: type "code_m" to show transactions with code "M".
| Filing Date | Transaction Date | Operation Date | Original Filing | Reporter | Relation | Opr | Amounta | %(Owned)b | ‱(SO)c | Avg Prcd | Account | Type | Full Name | Code | Remain | Shares Outstanding (Million)e |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2023-09-06 | 2023-09-01 | 2023-09-01 | 4 | Mcdonnell Michael R | EVP, CHIEF FINANCIAL OFFICER | dsp | 8048.0 | 100.0 | 0.56 | 0.0 | Direct | Restricted Stock Unit | BIOGEN INC. | code J M | 0.0
|
144.82 (BIIB) |
| 2024-01-31 | 2024-01-29 | 2024-01-29 | 4 | Mcdonnell Michael R | EVP, CHIEF FINANCIAL OFFICER | acq | 4568.0 | 100.0 | 0.32 | 0.0 | Direct | Performance Stock Unit | BIOGEN INC. | code A | 4568.0 | 144.9 (BIIB) |
| 2024-02-09 | 2024-02-07 | 2024-02-07 | 4 | Mcdonnell Michael R | EVP, CHIEF FINANCIAL OFFICER | acq | 6650.0 | 100.0 | 0.46 | 0.0 | Direct | Restricted Stock Unit | BIOGEN INC. | code A | 6650.0 | 144.9 (BIIB) |
| 2024-02-09 | 2024-02-07 | 2024-02-08 | 4 | Mcdonnell Michael R | EVP, CHIEF FINANCIAL OFFICER | dsp | 2335.0 | 33.33 | 0.16 | 0.0 | Direct | Restricted Stock Unit | BIOGEN INC. | code M | 4670.0 | 144.9 (BIIB) |
| 2024-02-13 | 2024-02-09 | 2024-02-09 | 4 | Mcdonnell Michael R | EVP, CHIEF FINANCIAL OFFICER | dsp | 3257.0 | 50.0 | 0.22 | 0.0 | Direct | Restricted Stock Unit | BIOGEN INC. | code M | 3257.0 | 144.9 (BIIB) |
| 2024-02-21 | 2024-02-16 | 2024-02-16 | 4 | Mcdonnell Michael R | EVP, CHIEF FINANCIAL OFFICER | dsp | 4836.0 | 100.0 | 0.33 | 0.0 | Direct | Restricted Stock Unit | BIOGEN INC. | code J M | 0.0
|
145.36 (BIIB) |
| 2024-02-21 | 2024-02-16 | 2024-02-16 | 4 | Mcdonnell Michael R | EVP, CHIEF FINANCIAL OFFICER | dsp | 4568.0 | 100.0 | 0.31 | 0.0 | Direct | Performance Stock Unit | BIOGEN INC. | code M | 0.0 | 145.36 (BIIB) |
a Sum of same type of securities in the form
b Relative to reporter's shares owned before (disposition) or after (acquisition) operation
c Relative to issuer's shares outstanding (1/10000)
d Average price for securities of the same type. Check the original form for detailed prices of multiple transactions
e Documented shares outstanding closest to the transaction date
Note: Corporate may change mapped CIK when merge or spin-off happen. Please report error if the ticker you searched for does not have up-to-date insider trading information.
Show up to records per table for current tier. Access Guide)